Skip to content

The molecular mechanism of HPD-related tyrosinemia regulated by TTC36 protein

The molecular mechanism of HPD-related tyrosinemia regulated by TTC36 protein

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032380
Enrollment
Unknown
Registered
2020-04-27
Start date
2020-04-21
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amino acid metabolism

Interventions

Sponsors

People's Hospital of Longhua District
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: Fresh normal liver tissue or normal tissue adjacent liver cancer.

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

MeasureTime frame
TTC36 interacting protein;

Countries

China

Contacts

Public ContactYunhong Liu

People's Hospital of Longhua District

liuyunhong2001@163.com+86 13408031252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026